Showing results (81-90 of 211) with videos related to
Sort By:
Pageof 22
Journal of Clinical Lipidology|September 27, 2012
Phenotypes of hypertriglyceridemia caused by excess very-low-density lipoproteinAllan D Sniderman, Andre Tremblay, Jacqueline De Graaf, et al.Trials|November 25, 2011
Five years of TrialsDouglas G Altman, Iain Hrynaszkiewicz, Curt D Furberg, et al.Annals of Internal Medicine|July 9, 2004
ALLHAT: setting the record straightBarry R Davis, Curt D Furberg, Jackson T Wright, et al.Atherosclerosis|April 22, 2014
Calculation of LDL apoBAllan D Sniderman, André J Tremblay, Jacqueline De Graaf, et al.Journal of the American Heart Association|July 25, 2023
Standardization of Apolipoprotein B, LDL-Cholesterol, and Non-HDL-CholesterolJohn H Contois, Michel R Langlois, Christa Cobbaert, et al.Diabetes Care|March 5, 2002
Hypertriglyceridemic hyperapoB in type 2 diabetesAllan D Sniderman, Benoit Lamarche, Jessica Tilley, et al.Current Opinion in Lipidology|October 12, 2011
Should preclinical vascular abnormalities be measured in asymptomatic adults to improve cardiovascular risk stratification?Jacqueline de Graaf, Suzanne Holewijn, Anton F Stalenhoef, et al.Current Opinion in Lipidology|October 24, 2014
Discordance analysis and the Gordian Knot of LDL and non-HDL cholesterol versus apoBAllan D Sniderman, Benoit Lamarche, John H Contois, et al.International Journal of Epidemiology|May 19, 2007
Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesisAllan D Sniderman, Raj Bhopal, Dorairaj Prabhakaran, et al.Nephrology (Carlton, Vic.)|October 9, 2016
Serial versus single troponin measurements for the prediction of cardiovascular events and mortality in stable chronic haemodialysis patientsThomas A Mavrakanas, Allan D Sniderman, Paul E Barré, et al.Pageof 22